Méthodes statistiques pour les essais de phase I/II de thérapies moléculaires ciblées en cancérologie
Les essais cliniques de phase I en cancérologie permettent d’identifier la dose optimale (DO), définie comme la dose maximale tolérée (DMT). Les approches conventionnelles de recherche de dose reposent uniquement sur les événements de toxicité observés au cours du premier cycle de traitement. Le dév...
Main Author: | Altzerinakou, Maria Athina |
---|---|
Other Authors: | Paris Saclay |
Language: | fr |
Published: |
2018
|
Subjects: | |
Online Access: | http://www.theses.fr/2018SACLS375/document |
Similar Items
-
Concept of cumulative dose in Ayurveda with special reference to metallic Bhasma
by: Pravin Jawanjal, et al.
Published: (2020-01-01) -
Estimation of the annual cumulative radiation dose received by the dentist in dental clinics in Chennai
by: Sanarpalayam Chinaswamy Selvamuthukumar, et al.
Published: (2014-01-01) -
Detection of subclinical anthracycline induced cardiotoxicity in breast cancer survivors
by: Preety Negi, et al.
Published: (2014-01-01) -
Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study
by: Jolanta Żok, et al.
Published: (2021-05-01) -
Cumulative effects of low X-ray doses on some liver function and proteins of diagnostic technicians working in conventional X-rays
by: Kharman Akram Faraj
Published: (2021-06-01)